| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T154 |
0-142 |
Sentence |
denotes |
Neurological manifestations of COVID-19 may be mild and diffuse, such as headache and myalgia or severe, such as intracranial infections [50]. |
| T155 |
143-265 |
Sentence |
denotes |
While severe neurological symptoms have been reported and are associated with worse outcomes, they appear to be rare [50]. |
| T156 |
266-491 |
Sentence |
denotes |
It is important in this connection to note that COVID-19 may cause specific neurological symptoms, exacerbate preexisting neurological conditions, or unmask preexisting neurological conditions that had not yet been diagnosed. |
| T157 |
492-618 |
Sentence |
denotes |
Any number of infections can unmask an undiagnosed neurological condition, resulting in their overt emergence or exacerbation. |
| T158 |
619-784 |
Sentence |
denotes |
Thus, a portion of COVID-associated neurological and neuromuscular symptoms may be unmasked in the pandemic rather than directly caused by the SARS-CoV-2 virus [70]. |
| T159 |
785-1378 |
Sentence |
denotes |
In a study from the United Kingdom of 43 patients with a confirmed COVID-19 diagnosis or where the diagnosis of COVID-19 was deemed ‘probable’ or ‘possible’ based on World Health Organization criteria, 10/43 patients had encephalopathy with delirium/psychosis and no abnormalities on magnetic resonance imaging or in cerebrospinal fluid, 12/43 exhibited inflammatory syndromes of the central nervous system, including encephalitis, 8/43 had ischemic stroke, 8/43 had peripheral neurological disorders (predominantly Guillain-Barré syndrome), and 5/43 with miscellaneous central disorders [71]. |
| T160 |
1379-1474 |
Sentence |
denotes |
These neurological disorders were similar to those associated with other coronavirus epidemics. |
